Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neuronetics Inc
(NQ:
STIM
)
3.810
+0.310 (+8.86%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
41,783
Open
3.590
Bid (Size)
3.600 (1)
Ask (Size)
4.650 (1)
Prev. Close
3.500
Today's Range
3.500 - 3.860
52wk Range
1.030 - 5.070
Shares Outstanding
29,756,053
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month
May 01, 2024
The Company is highlighting stories from adolescents with major depressive disorder on the heels of groundbreaking FDA clearance
From
Neuronetics
Via
GlobeNewswire
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
April 10, 2024
Lack of early symptom improvement is not predictive of final responder status
From
Neuronetics
Via
GlobeNewswire
Performance
YTD
+38.55%
+38.55%
1 Month
-10.14%
-10.14%
3 Month
+12.72%
+12.72%
6 Month
+172.14%
+172.14%
1 Year
+69.33%
+69.33%
More News
Read More
Top 5 Health Care Stocks That May Plunge In March
March 28, 2024
Via
Benzinga
Earnings Outlook For Neuronetics
March 04, 2024
Via
Benzinga
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 25, 2024
Via
Benzinga
NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
March 25, 2024
From
Neuronetics
Via
GlobeNewswire
Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
March 07, 2024
From
Neuronetics
Via
GlobeNewswire
Earnings Scheduled For March 5, 2024
March 05, 2024
Via
Benzinga
Neuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System
February 12, 2024
From
Neuronetics
Via
GlobeNewswire
NeuroStar TMS Patient Access Expands Through Lucet Health Policy Update
February 06, 2024
From
Neuronetics
Via
GlobeNewswire
Neuronetics Receives 510(k) Clearance for NeuroSite™ Coil Placement Accessory
December 18, 2023
From
Neuronetics
Via
GlobeNewswire
NeuroStar TMS Receives Expanded Regulatory Approval in Japan
December 04, 2023
From
Neuronetics
Via
GlobeNewswire
NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements
November 13, 2023
From
Neuronetics
Via
GlobeNewswire
Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage
November 09, 2023
From
Neuronetics
Via
GlobeNewswire
Brain Stimulation Highlights Best Practices for Optimal TMS Treatment Outcomes
October 16, 2023
From
Neuronetics
Via
GlobeNewswire
Earnings Scheduled For November 7, 2023
November 07, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
September 21, 2023
Via
Benzinga
In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression
September 12, 2023
From
Neuronetics
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
September 07, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 22, 2023
Via
Benzinga
NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards
August 21, 2023
From
Neuronetics
Via
GlobeNewswire
Neuronetics Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar® Platform
August 14, 2023
From
Neuronetics
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
August 11, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
August 11, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.